FRCPath Haem Part 1 MCQ-Oncology 261

A 60yr-old pt with relapsed multiple myeloma, receiving second line treatment reports blurred vision and photophobia. Likely cause of the symptoms.

• Talquetamab
• Teclistamab
• Elranatamab
• Belantamab

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now